Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study

Annals of Oncology : Official Journal of the European Society for Medical Oncology
C RipamontiF De Conno

Abstract

Cancer pain can be treated in most cases with oral analgesics. However, during their clinical history, 53% to 70% of patients will need alternative routes of opioid administration. The rectal administration of opioids is a simple alternative route for many patients. There are no data in the literature regarding the pharmacodynamics and pharmacokinetics of rectal methadone. We evaluated the analgesia, tolerability and absorption profile of methadone hydrochloride in six opioid-naive cancer patients with pain. A blood sample was collected before administration of a single dose of drug (10 mg) and then again after fixed times. At these fixed times the patients were asked about pain, nausea and drowsiness by means of a visual analogue scale of 0-100 mm (VAS). Pain relief was statistically significant as early as 30 minutes and up to eight hours after methadone administration. None of the patients reported significant side effects. The pharmacokinetics of rectal methadone showed rapid and extensive distribution phases followed by a slow elimination phase. Rectal methadone can be considered an effective analgesic therapy for patients with cancer pain for whom oral and/or parenteral opioids are not indicated or available.

Citations

Dec 2, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Wojciech Leppert
Jul 3, 2009·International Journal of Clinical Practice·W Leppert
Feb 27, 2013·Expert Opinion on Pharmacotherapy·Daniele SantiniCarla Ripamonti
Jan 13, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sebastiano MercadanteCarla Ripamonti
Feb 13, 2002·Journal of Palliative Medicine·Eduardo Bruera, Catherine Sweeney
Jul 17, 2004·British Journal of Clinical Pharmacology·Ola DaleEvan D Kharasch
Jan 27, 2007·Current Oncology Reports·John BrysonCamilla Zimmermann
Aug 27, 2015·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Thien C PhamRobert B Raffa
Dec 29, 1998·The American Journal of Hospice & Palliative Care·S G Mercadante
Jul 11, 2000·Current Opinion in Oncology·I ManciniJ J Body
May 1, 1996·Cancer Control : Journal of the Moffitt Cancer Center·C Ripamonti, E Bruera
Jan 1, 1997·European Journal of Pain : EJP·S Mercadante
Sep 13, 2018·Journal of Palliative Medicine·Katie ElsassNatalie Malone
Apr 3, 2012·Drugs & Aging·Eric Prommer, Brandy Ficek
Nov 26, 2003·Journal of Pain & Palliative Care Pharmacotherapy·Kenneth S Latta
Jun 22, 2020·CNS Drugs·Denise Kreutzwiser, Qutaiba A Tawfic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revista española de anestesiología y reanimación
C Hernández AguadoM A Nalda Felipe
The American Journal of Nursing
C Pasero, M McCaffery
The American Journal of Hospice Care
A G Lipman
© 2021 Meta ULC. All rights reserved